Blog
RSS FeedPosted by Michael Wonder on 18 May 2021
Quebec announces intention to implement a biosimilar switching policy
18 May 2021 - Biosimilars Canada today congratulated the Government of Quebec and Minister of Health and Social Services Christian ...
Posted by Michael Wonder on 18 May 2021
Belgium seeks to encourage generic drugs with new prescription reimbursement structure
18 May 2021 - The federal government has decided to increase the percentage by which generic drugs will be reimbursed, ...
Posted by Michael Wonder on 18 May 2021
Pharmaceutical company AbbVie inflated prices for two major drugs, House Oversight report says
18 May 2021 - The House Oversight and Reform Committee found that the company increased prices for Humira and Imbruvica. ...
Posted by Michael Wonder on 18 May 2021
Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars
18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...
Posted by Michael Wonder on 18 May 2021
U.S. FDA accepts regulatory submission for sintilimab in combination with pemetrexed and platinum chemotherapy for the first-line treatment of people with non-squamous non-small cell lung cancer
18 May 2021 - Innovent Biologics and Eli Lilly today jointly announced that the U.S. FDA accepted for review a biologics ...
Posted by Michael Wonder on 18 May 2021
PHARMAC, dental funding crucial in Budget - National Party
18 May 2021 - Thursday's Budget is being promoted as a Covid-19 Recovery Budget. ...
Posted by Michael Wonder on 18 May 2021
PBS win to bring relief for people with migraine but concerns over limitations remain
16 May 2021 - For Devonport resident Nette Judson a migraine attack causes her to struggle to walk and talk ...
Posted by Michael Wonder on 17 May 2021
AffyImmune Therapeutics' AIC100 granted fast track designation for treating thyroid cancer
17 May 2021 - AffyImmune Therapeutics announced today that the US FDA granted fast track designation to its lead compound, AIC100, ...
Posted by Michael Wonder on 17 May 2021
Sandoz Canada launches its 6th biosimilar with Inclunox and Inclunox HP (enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (high potency))
17 May 2021 - New Sandoz biosimilar launch can potentially lower healthcare costs, especially for Canadian hospitals, as 75% of the ...
Posted by Michael Wonder on 17 May 2021
Statement on leronlimab
17 May 2021 - FDA recognizes the substantial public interest in medicines that are being studied for the prevention or treatment ...
Posted by Michael Wonder on 17 May 2021
New Zealanders living with cystic fibrosis wait for 'life changing' drug
16 May 2021 - Edward Lee and Reese Robertson both have cystic fibrosis. ...
Posted by Michael Wonder on 17 May 2021
US Supreme Court denies Sandoz petition to review biosimilar Erelzi (etanercept-szzs) case
17 May 2021 - Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable ...
Posted by Michael Wonder on 17 May 2021
Biogen hopes Alzheimer’s drug mired in controversy earns FDA nod
13 May 2021 - After scores of failures, regulators are set to rule on aducanumab, which promises to slow dementia. ...
Posted by Michael Wonder on 17 May 2021
Optimising managed access: lessons from the Cancer Drugs Fund
14 May 2021 - The desire, opportunity, and willingness to increase access to potentially life saving cancer treatments has mounted in ...
Posted by Michael Wonder on 17 May 2021
TGA weighs over the counter contraceptive pill plan
17 May 2021 - The nation’s medicines regulator is looking at a plan to give Australians more freedom to access ...